帕金森病中的 Habenula 体积变化: 7T MRI 研究
Bedia Samanci1, Sonny Tan2, Stijn Michielse3
1School for Mental Health and Neurosciences, Maastricht University, Maastricht, the Netherlands; Behavioral Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Brain research bulletin
|June 13, 2024
概括
帕金森病患者表现出更大的骨髓体积,与抑郁症得分无关. 这种神经解剖学变化可能与运动症状有关,而不是情绪.
科学领域:
- 神经科学是一个神经科学.
- 放射学 放射学是一门学科.
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病,具有运动和非运动症状.
- 大脑结构的哈本拉与抑郁症有关.
- 在不患抑郁症的PD患者中研究 habenula 对于了解PD特定变化至关重要.
研究的目的:
- 在没有临床抑郁症的帕金森病患者中检查 Habenular 体积差异.
- 为了确定 Habenular 体积与 PD 中的抑郁症得分是否相关.
- 为了探索 habenula 在PD 病理生理学中的作用,独立于抑郁症.
主要方法:
- 利用了来自104名PD患者和44名健康对照 (HC) 的7个特斯拉MRI数据.
- 手动细分了 habenula 来测量其体积.
- 使用贝克抑郁 inventory (BDI) 评估抑郁症,并与 Habenular 体积相关联.
主要成果:
- 与HC相比,PD患者的平均和右半球体积显著增加.
- 在任何一组中都没有观察到 habenular体积和BDI得分之间的显著相关性.
- 患有PD的患者表现出更高的BDI得分,表明低于值的抑郁症,但这与 Habenular 尺寸无关.
结论:
- 在这种队列中,PD中的Habenular体积变化可能与抑郁症没有直接关系.
- 这些结构变化可能与帕金森病的运动症状有关.
- 需要进一步的研究才能充分阐明 habenula 在 PD 中的神经解剖学作用.
更多相关视频
10:27In Vivo Morphometric Analysis of Human Cranial Nerves Using Magnetic Resonance Imaging in Menière's Disease Ears and Normal Hearing Ears
Published on: February 21, 2018
10.6K
05:14Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
3.4K
相关概念视频
Neural Regulation
39.3K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.3K
Parkinson's Disease: Overview
524
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
524
Parkinson's Disease: Treatment
255
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
255
